Syros Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 2.75 M | $631,985 | 0.00% | 7.00% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 1.54 M | $354,168 | 24.87% | 3.92% |
| BLACKROCK, INC. | 02/07/2025 | 277,253 | $63,713 | 5.99% | 0.71% |
| VANGUARD GROUP INC | 02/11/2025 | 268,154 | $61,675 | -71.87% | 0.68% |
| OMEGA FUND MANAGEMENT, LLC | 02/14/2025 | 251,270 | $57,792 | 0.00% | 0.64% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 249,426 | $55,000 | 371.81% | 0.64% |
| CITADEL ADVISORS LLC | 02/14/2025 | 209,900 | $48,235 | 417.00% | 0.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 196,252 | $45,119 | -4.12% | 0.50% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 150,000 | $34,470 | 100.00% | 0.38% |
| CITIGROUP INC | 02/12/2025 | 139,224 | $31,994 | 20,165.50% | 0.35% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 122,174 | $28,076 | 57.21% | 0.31% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 107,742 | $24,759 | 100.00% | 0.27% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 96,042 | $22,070 | -0.41% | 0.24% |
| HRT FINANCIAL LP | 02/14/2025 | 87,535 | $20,000 | 100.00% | 0.22% |
| XTX TOPCO LTD | 02/13/2025 | 81,460 | $18,720 | 182.51% | 0.21% |
| 1492 CAPITAL MANAGEMENT LLC | 02/13/2025 | 39,244 | $9,018 | 0.00% | 0.10% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 32,791 | $8,000 | 67.05% | 0.08% |
| BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 22,092 | $4,545 | 100.00% | 0.06% |
| CLARIUS GROUP, LLC | 01/16/2025 | 18,620 | $4,279 | 0.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 13,900 | $3,197 | -74.82% | 0.04% |
| CI PRIVATE WEALTH, LLC | 02/10/2025 | 12,000 | $2,758 | 0.00% | 0.03% |
| CENTERPOINT ADVISORS, LLC | 01/31/2025 | 10,659 | $2,000 | 0.00% | 0.03% |
| 02/13/2025 | 9,970 | $2,291 | 0.00% | 0.03% | |
| FNY INVESTMENT ADVISERS, LLC | 01/13/2025 | 5,100 | $1,000 | 100.00% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 4,500 | $1,035 | 0.00% | 0.01% |
| TORNO CAPITAL, LLC | 02/14/2025 | 4,000 | $919 | 100.00% | 0.01% |
| 02/06/2025 | 1,883 | $433 | 100.00% | 0.00% | |
| CITADEL ADVISORS LLC | 02/14/2025 | 1,700 | $391 | -95.39% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 212 | $48 | -69.93% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 87 | $20 | 0.00% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 01/21/2025 | 76 | $17 | 0.00% | 0.00% |
| PSI ADVISORS, LLC | 01/13/2025 | 13 | $3 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/10/2025 | 10 | $2 | 100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 8 | $2 | 0.00% | 0.00% |
| FIFTH THIRD BANCORP | 01/21/2025 | 0 | $0 | -100.00% | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS OCONNOR LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FLAGSHIP PIONEERING INC. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WISER WEALTH MANAGEMENT, INC | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syros Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 70 institutional investors and hedge funds held shares of Syros Pharmaceuticals, Inc.. The most heavily invested institutionals were:
PSI Advisors, LLC: 0
FNY Investment Advisers, LLC: 0
Clarius Group, LLC: 0
Sound Income Strategies, LLC: 0
Bain Capital Life Sciences Investors, LLC: 2.75 M
BlackRock, Inc.: 277,253
13.29% of Syros Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 11.60 M shares in the last 24 months. This purchase volume represents approximately $1.36 M in transactions.